Xtant Medical Holdings, Inc. (XTNT)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-13) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-31) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-10) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 · 99.2 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-12) · 99.1 | 8-K (2025-04-16) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-06) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-15) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-04-01) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-09) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-01) · 99.1 | 8-K (2023-07-03) · 99.1 · 99.2 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Comprehensive Income (loss) | ||
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Comprehensive Loss (unaudited) | — |
|
| Consolidated Statements of Comprehensive (loss) Income | ||
| Condensed Consolidated Statements of Equity (unaudited) | — |
|
| Consolidated Statements of Changes In Stockholders' Equity | — |
|
| Condensed Consolidated Statements of Equity (unaudited) (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Changes In Stockholders' Equity (P) | — |
|
| Notes | ||
| Accrued Liabilities | ||
| Acquisition of Coflex and Cofix Product Lines | ||
| Acquisition of Nanoss Production Operations | ||
| Acquisition of Surgalign Holdings, Inc.s Hardware and Biologics Business | ||
| Asset Purchase Agreement | — |
|
| Award Timing Disclosure | — |
|
| Business Description and Summary of Significant Accounting Policies | — |
|
| Business Description, Basis of Presentation and Summary of Significant Accounting Policies | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Employee Benefit Plans | — |
|
| Equity | — |
|
| Goodwill and Intangible Assets | — |
|
| Immaterial Correction To Prior Period Financial Statements | — |
|
| Immaterial Out-of-period Adjustment | — |
|
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | — |
|
| Inventories | ||
| Net (loss) Income Per Share | ||
| Net Income (loss) Per Share | ||
| Pay Vs Performance Disclosure | ||
| Pending Sale of Coflex/cofix Assets and International Hardware Business | — |
|
| Property and Equipment, Net | ||
| Receivables | ||
| Related Party Transactions | ||
| Revenue | — |
|
| Sale of Coflex/cofix Assets and International Hardware Business | ||
| Segment and Geographic Information | ||
| Stock-based Compensation | ||
| Subsequent Event | ||
| Supplemental Disclosure of Cash Flow Information | ||
| Trade Accounts Receivable, Net | ||
| Warrants | ||